Apoptosis
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
What is Apoptosis? The Apoptotic Pathways and the Caspase Cascade
Targets for Apoptosis
- Pyroptosis(32)
- Caspase(68)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(41)
- Bax(8)
- Bcl-2 Family(122)
- Bcl-xL(8)
- c-RET(8)
- IAP(27)
- KEAP1-Nrf2(70)
- MDM2(13)
- p53(124)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(149)
- Other Apoptosis(884)
- Apoptosis Detection(0)
- Caspase Substrate(0)
- APC(6)
- PD-1/PD-L1 interaction(91)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Cuproptosis(3)
Products for Apoptosis
- Cat.No. Product Name Information
-
GC15878
Atractyloside Dipotassium Salt
Inhibitor of ADP/ATP translocases
-
GC72319
Atrosab
Atrosab is a humanized IgG1 antagonistic anti-TNFR1 antibody.
-
GC39699
Aurintricarboxylic acid
Aurintricarboxylic acid is a nanomolar-potency, allosteric antagonist with selectivity towards αβ-methylene-ATP-sensitive P2X1Rs and P2X3Rs, with IC50s of 8.6 nM and 72.9 nM for rP2X1R and rP2X3R, respectively.
-
GC46895
Aurintricarboxylic Acid (ammonium salt)
ATA
A protein synthesis inhibitor with diverse biological activities -
GC13332
Aurora A Inhibitor I
A potent and selective inhibitor of Aurora A kinase
-
GC15295
AUY922 (NVP-AUY922)
VER-52296, AUY-922, AUY 922, Luminespib
AUY922 (NVP-AUY922) is a potent and selective inhibitor of HSP90, effectively inhibiting both HSP90α and HSP90β with similar IC50 values of 13nM and 21nM, respectively. -
GC31719
Avelumab (Anti-Human PD-L1, Human Antibody)
Avelumab (Anti-Human PD-L1, Human Antibody) is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.
-
GC72858
Avenanthramide A
Avenanthramide A is a ptoalexin, which can be found in oats (Avena sativa L.
-
GC42880
Avenanthramide-C methyl ester
Avenanthramide-C methyl ester is an inhibitor of NF-κB activation that acts by blocking the phosphorylation of IKK and IκB (IC50 ~ 40 μM).
-
GC35440
AX-024
AX-024 is an orally available, first-in-class inhibitor of the TCR-Nck interaction that selectively inhibits TCR-triggered T cell activation with an IC50 ~1 nM.
-
GC19046
AX-024 hydrochloride
AX-024 hydrochloride is an cytokine release inhibitor which can strongly inhibit the production of interleukin-6 (IL-6), tumor necrosis factor-α (TNFα), interferon-γ (IFN-γ), IL-10 and IL-17A.
-
GC17045
AXL1717
AXL 1717, NSC 36407, Picropodophyllin, PPP
A potent and selective inhibitor of IGF-1R -
GC15055
AZ 628
AZ-628; AZ628
Raf kinases,potent and ATP-competitive
-
GC13433
AZ 960
A JAK2 inhibitor
-
GC72868
AZA197
AZA197 is a selective small molecule inhibitor of Cdc42.
-
GC46901
Azadirachtin
A naturally-occurring insecticide
-
GC15033
Azathioprine
Azamune, Azoran, BW 57322, Imuran, NSC 39084
purine synthesis and GTP-binding protein Rac1 activation inhibitor -
GC48971
AZD 1152 (hydrochloride)
Barasertib
A prodrug for a potent Aurora B inhibitor -
GC18566
AZD 3147
A dual mTORC1/mTORC2 inhibitor
-
GC50109
AZD 5582 dihydrochloride
Dimeric Smac mimetic; potent IAP inhibitor
-
GC33247
AZD-5991
An Mcl-1 inhibitor
-
GC33283
AZD-5991 Racemate
AZD-5991 Racemate is the racemate of AZD-5991. AZD-5991 Racemate is a Mcl-1 inhibitor with an IC50 of <3 nM in FRET assay.
-
GC33239
AZD-5991 S-enantiomer
AZD-5991 S-enantiomer is the less active enantiomer of AZD-5991. AZD-5991 S-enantiomer is a Mcl-1 inhibitor with an IC50 of 6.3 μM in FRET assay and a Kd of 0.98 μM in surface plasmon resonance (SPR) assay.
-
GC64938
AZD-7648
AZD-7648 is a potent, orally active, selective DNA-PK inhibitor with an IC50 of 0.6 nM. AZD-7648 induces apoptosis and shows antitumor activity.
-
GC12660
AZD1208
AZD 1208;AZD-1208
AZD1208 is a potent, highly selective, and orally available Pim kinase inhibitor, with IC50 values of 0.4, 5, and 1.9nM for PIM1, PIM2, and PIM3, respectively. -
GC13029
AZD2014
AZD 2014; AZD-2014
AZD2014 (AZD2014) is an ATP competitive mTOR inhibitor with an IC50 of 2.81 nM. AZD2014 inhibits both mTORC1 and mTORC2 complexes. -
GC33255
AZD4320
AZD4320 is a novel BH3-mimicking dual BCL2/BCLxL inhibitor with IC50s of 26 nM, 17 nM, and 170 nM for KPUM-MS3, KPUM-UH1, and STR-428 cells, respectively.
-
GC73016
AZD4877
AZD4877 is another isostere to Ispinesib and also a kinesin spindle protein (Eg5) inhibitor with IC50 of 2 nM.
-
GC19050
AZD5582
AZD5582 is a novel class of dimeric Smac mimetics as potent IAP antagonist; binds potently to the BIR3 domains of cIAP1, cIAP2, and XIAP (IC50 = 15, 21, and 15 nM, respectively).
-
GC16380
AZD8055
CCG-168
AZD8055 is a new ATP-competitive mTOR inhibitor with an IC50 of 0.8 nmol/L and a Ki of 1.3 nmol/L.
-
GC19054
Azoramide
Azoramide is a small-molecule modulator of the unfolded protein response with antidiabetic activity.
-
GC46904
Azoxystrobin
ICI-A 5504
A broad-spectrum fungicide -
GC60616
AZT triphosphate
3'-Azido-3'-deoxythymidine-5'-triphosphate
AZT triphosphate (3'-Azido-3'-deoxythymidine-5'-triphosphate) is a active triphosphate metabolite of Zidovudine (AZT). -
GC60617
AZT triphosphate TEA
3'-Azido-3'-deoxythymidine-5'-triphosphate TEA
AZT triphosphate TEA (3'-Azido-3'-deoxythymidine-5'-triphosphate TEA) is a active triphosphate metabolite of Zidovudine (AZT). -
GC35458
Bacopaside II
A triterpene glycoside
-
GC72817
BAI1 hydrochloride
BAI1 drochloride is a selective apoptosis factor BAX allosteric inhibitors.
-
GC34263
Bak BH3
Bak BH3 is derived from the BH3 domain of Bak, can antagonize the function of Bcl-xL in cells.
-
GC52344
Bak BH3 (72-87) (human) (trifluoroacetate salt)
A Bak-derived peptide
-
GC12053
BAM7
BAM 7;BAM-7
A direct activator of Bax -
GN10507
Baohuoside I
Icariin II, Icariside II
Baohuoside I, a flavonoid isolated from Epimedium koreanum Nakai, acts as an inhibitor of CXCR4, downregulates CXCR4 expression, induces apoptosis and shows anti-tumor activity. -
GC15371
Bardoxolone
Bardoxolone, RTA 401
An anti-inflammatory compound that activates Nrf2/ARE signaling -
GC11572
Bardoxolone methyl
Bardoxolone methyl, NSC 713200, RTA 402, TP155
A synthetic triterpenoid with potent anticancer and antidiabetic activity -
GC60620
Batabulin
Batabulin (T138067) is an antitumor agent, which binds covalently and selectively to a subset of the β-tubulin isotypes, thereby disrupting microtubule polymerization. Batabulin affects cell morphology and leads to cell-cycle arrest ultimately induces apoptotic cell death.
-
GC60621
Batabulin sodium
T138067
An inhibitor of tubulin polymerization -
GC68729
Bax activator-1
Bax activator-1 (compound 106) is a Bax activator that induces Bax-dependent apoptosis in tumor cells.
-
GC12763
Bax channel blocker
-
GC16023
Bax inhibitor peptide P5
Bax inhibitor
-
GC17195
Bax inhibitor peptide V5
BIP-V5; BAX Inhibiting Peptide V5
A Bax inhibitor -
GC52476
Bax Inhibitor Peptide V5 (trifluoroacetate salt)
BIP V5, VPMLK
A Bax inhibitor -
GC16695
Bax inhibitor peptide, negative control
Peptide inhibit Bax translocation to mitochondria
-
GC10345
Bay 11-7085
NK-κB activation inhibitor
-
GC13035
Bay 11-7821
BAY 11-7082
Bay 11-7821(BAY 11-7082) is an inhibitor of IκBα phosphorylation and NF-κB, selectively and irreversibly inhibits TNF-α-induced IκB-α phosphorylation (IC50 value is approximately 10μM), and reduces the expression of NF-κB and adhesion molecules. Bay 11-7821 inhibits ubiquitin-specific proteases USP7 and USP21 with IC50 values of 0.19 and 0.96μM, respectively . -
GC73719
BAY 1892005
BAY 1892005 is a regulator of p53 protein and acts on p53 condensates without causing mutant p53 reactivation.
-
GC73918
BAY 249716
BAY 249716 stabilizes all three p53 protein variants.
-
GC16389
BAY 61-3606
A Syk inhibitor
-
GC42897
BAY 61-3606 (hydrochloride)
BAY 61-3606 is a cell-permeable, reversible inhibitor of spleen tyrosine kinase (Syk; Ki = 7.5 nM; IC50 = 10 nM).
-
GC12136
BAY 61-3606 dihydrochloride
BAY61-3606 dihydrochloride;BAY 61-3606
-
GC62164
BAY1082439
BAY1082439 is an orally bioavailable, selective PI3Kα/β/δ inhibitor. BAY1082439 also inhibits mutated forms of PIK3CA. BAY1082439 is highly effective in inhibiting Pten-null prostate cancer growth.
-
GC71008
BBR-BODIPY
BBR-BODIPY is a fluorescent probe that allows screening its interaction with the targeted cells.
-
GC68744
BC-?1258
BC-1258 is an activator of F-box/LRR-repeat protein 2 (FBXL2) that stabilizes and upregulates FBXL2 levels. BC-1258 induces apoptosis in tumor cells and significantly inhibits tumor formation in mice.
-
GC16516
BCH
2-amino-2-Norbornanecarboxylic Acid
BCH (BCH) is a selective and competitive inhibitor of large neutral amino acid transporter 1 (LAT1) significantly inhibit cellular uptake of amino acids and mTOR phosphorylation, which induces the suppression of cancer growth and apoptosis. -
GC63325
Bcl-xL antagonist 2
Bcl-xL antagonist 2 is a potent, selective, and orally active antagonist of BCL-XL with an IC50 and Ki of 0.091 μM and 65 nM, respectively. Bcl-xL antagonist 2 promotes the apoptosis of cancer cells. Bcl-xL antagonist 2 has the potential for the research of the chronic lymphocytic leukemia (CLL) and non-Hodgkin’s lymphoma (NHL).
-
GC62599
BCL6-IN-4
BCL6-IN-4 is a potent B-cell lymphoma 6 (BCL6) inhibitor with an IC50 of 97 nM. BCL6-IN-4 has anti-tumor activities.
-
GC68012
BCL6-IN-7
-
GC10721
BDA-366
BDA-366 is a potent Bcl2 antagonist (Ki = 3.3 nM), binding Bcl2-BH4 domain with high affinity and selectivity. BDA-366 induces conformational change in Bcl2 that abrogates its antiapoptotic function, converting it from a survival molecule to a cell death inducer. BDA-366 suppresses growth of lung cancer cells.
-
GC73928
BDM19
BDM19 binds and activates cytosolic BAX dimers, and prompts cell apoptosis either alone or in combination with BCL-2/BCL-XL inhibitor Navitoclax.
-
GC42912
Becatecarin
BMS 181176, BMY 27557, NSC 655649, XL 119
Becatecarin is a water-soluble, diethylaminoethyl analog of the antineoplastic antibiotic rebeccamycin. -
GC68369
Belantamab
GSK2857914
-
GC72851
Belapectin
GR-MD-02
Belapectin (GR-MD-02) is a Galectin-3 (Gal-3) inhibitor. -
GC65031
Belimumab
Belimumab (LymphoStat B) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF).
-
GC49042
Benastatin A
A bacterial metabolite with diverse biological activities
-
GC64354
Bendamustine
Bendamustine (SDX-105 free base), a purine analogue, is a DNA cross-linking agent. Bendamustine activates DNA-damage stress response and apoptosis. Bendamustine has potent alkylating, anticancer and antimetabolite properties.
-
GC10744
Bendamustine HCl
SDX-105
Bendamustine HCl (SDX-105), a purine analogue, is a DNA cross-linking agent. Bendamustine HCl activats DNA-damage stress response and apoptosis. Bendamustine HCl has potent alkylating, anticancer and antimetabolite properties. -
GC46914
Bendamustine-d4 (hydrochloride)
A neuropeptide with diverse biological activities
-
GC49781
Benomyl
NSC 263489
A carbamate pesticide -
GC62451
Benpyrine
Benpyrine is a highly specific and orally active TNF-α inhibitor with a KD value of 82.1 μM.
-
GC74515
Benufutamab
GEN1029
Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody. -
GC49403
Benzarone
L 2197, NSC 82134
An active metabolite of benzbromarone -
GC14930
Benzbromarone
MJ10061, NSC 85433
TMEM16A/B calcium-activated chloride channel (CaCC) blocker -
GN10520
Benzoylpaeoniflorin
-
GC38683
Benzyl isothiocyanate
Benzyl isothiocyanate is a member of natural isothiocyanates with antimicrobial activity.
-
GN10358
Berbamine hydrochloride
-
GN10539
Bergenin
(-)-Bergenin, Cuscutin, NSC 661749
-
GC42925
Berteroin
5-Methylthiopentyl isothiocyanate
Berteroin is a sulforaphane analog found in cruciferous vegetables including Chinese cabbage, rucola salad leaves, and mustard oil. -
GC10734
Beta-Lapachone
ARQ 501, NSC 26326, NSC 629749, SL 11001
Beta-Lapachone (ARQ-501;NSC-26326) is a naturally occurring O-naphthoquinone, acts as a topoisomerase I inhibitor, and induces apoptosis by inhibiting cell cycle progression. -
GC20142
Beta-Sitosterol
β-Sitosterol (purity>98%); 22,23-Dihydrostigmasterol (purity>98%))
Beta-Sitosterol is a plant sterol with multiple biological activities, including anti-inflammatory, anti-tumor, antipyretic and immunomodulatory activities. -
GC35504
Beta-Zearalanol
Beta-Zearalenol is an mycotoxin produced by Fusarium spp, which causes apoptosis and oxidative stress in mammalian reproductive cells.
-
GC70742
Betamethasone-d5-1
Betamethasone-d5-1 is deuterium labeled Betamethasone.
-
GN10632
Betulin
(+)-Betulin, NSC 4644, Trochol
-
GC10480
Betulinic acid
Lupatic Acid, NSC 113090
Betulinic acid is a natural pentacyclic triterpenoid compound and an inhibitor of eukaryotic topoisomerase I with an IC50 value of 5 μM. -
GC48477
Betulinic Acid propargyl ester
An alkyne derivative of betulinic acid
-
GC48504
Betulinic Aldehyde oxime
Betulin 28-oxime
A derivative of betulin -
GC48520
Betulonaldehyde
(+)-Betulonal, Betulonic Aldehyde
A pentacyclic triterpenoid -
GC73940
BFC1108
BFC1108 is a small molecule Bcl-2 functional converter.
-
GC74043
Bfl-1-IN-2
Bfl-1-IN-2 (Compound 13) is a reversible and covalent inhibitor of Bfl-1 (IC50: 4.3 μM).
-
GC12074
BG45
Novel HDAC3-selective inhibitor
-
GC68757
BH3 hydrochloride
BH3 hydrochloride is a peptide that can penetrate the blood-brain barrier. It induces cell apoptosis by directly activating pro-apoptotic Bax/Bak or neutralizing anti-apoptotic Bcl-2 proteins (Bcl-2, Bcl-XL, Bcl-w, mcl1 and A-1) through binding to the BH3 domain.
-
GC18136
BH3I-1
BHI1; BH 3I1
Bcl-2 or Bcl-XL inhibitor -
GC35511
BI-0252
BI-0252 is an orally active, selective MDM2-p53 inhibitor with an IC50 of 4 nM. BI-0252 can induce tumor regressions in all animals of a mouse SJSA-1 xenograft, with concomitant induction of the tumor protein p53 (TP53) target genes and markers of apoptosis.
-
GC17828
BI-847325
dual inhibitor of MEK and Aurora kinases